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Abstract
There is strong evidence that rare variants are involved in complex disease etiology. The first step in implicating rare variants
in disease etiology is their identification through sequencing in both randomly ascertained samples (e.g., the 1,000
Genomes Project) and samples ascertained according to disease status. We investigated to what extent rare variants will be
observed across the genome and in candidate genes in randomly ascertained samples, the magnitude of variant
enrichment in diseased individuals, and biases that can occur due to how variants are discovered. Although sequencing
cases can enrich for casual variants, when a gene or genes are not involved in disease etiology, limiting variant discovery to
cases can lead to association studies with dramatically inflated false positive rates.
Citation: Li B, Leal SM (2009) Discovery of Rare Variants via Sequencing: Implications for the Design of Complex Trait Association Studies. PLoS Genet 5(5):
e1000481. doi:10.1371/journal.pgen.1000481
Editor: David B. Allison, University of Alabama at Birmingham, United States of America
Received January 29, 2009; Accepted April 13, 2009; Published May 15, 2009
Copyright:  2009 Li, Leal. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by National Institutes of Health grant R01-DC03594. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sleal@bcm.edu
Introduction
Genome wide association studies using indirect mapping have
been successful in localizing genes which are associated with
complex diseases when common variants are the underlying cause
of disease etiology [1,2]. Strong linkage disequilibrium (LD)
between tagSNPs and underlying causal variants makes it feasible
to use indirect mapping. To detect associations with rare variants
the indirect LD mapping will be low-powered due to weak
correlations between common tagSNPs and rare causal variants.
In order for variants to be highly correlated they must have similar
allele frequencies and the maximum r
2 value of 1 can be obtained
only when the two loci have equal minor allele frequencies [3].
Therefore for associations with rare variants it is necessary to
perform direct mapping and rare variants within a sample must
first be identified. Sequencing of candidate genes or entire
genomes is the optimal way to identify rare variants. A number
of studies have successfully used the approach of sequencing
candidate genes to carry out association studies for several
complex traits [4–11]. There is emerging interest in association
studies of rare variants and it is hypothesized that rare variants are
more likely to be functional than common variants [12]. Although
the genotypic RRs of rare causal variants are not elevated enough
to produce familial aggregation, they are considerably higher than
the genotypic RRs of common variants which are involved in
complex disease etiology [13]. New sequencing technologies (e.g.,
Illumina Solexa, ABI SOLiD, and Roche 454) [14] have greatly
reduced the cost of generating large amounts of sequencing data.
This advancement has enabled the launch of the 1,000 Genomes
Project, which will sequence at least 1,000 genomes from 10
different ethnic backgrounds. The project’s goals include provid-
ing a detailed catalog of human variants to facilitate the
identification of disease causing variants [15]. Even if the
assumption holds that all variants present in a sample can be
successfully identified through sequencing (i.e., no false negatives),
variants may not be observed within a sample solely due to the
randomness of sampling. Therefore we investigated three main
questions for a randomly ascertained sample of 100–1,000
individuals for variants with frequencies between 0.01% and
1.0%: (1) What is the probability that a variant will be discovered
at a specific site? (2) What proportion of variants will be uncovered
across the entire genome? and (3) What is the probability that a
certain proportion of variants will be discovered in a gene? It was
also investigated to what extent carrying out variant discovery in
cases increases the probability of uncovering causal variants
compared to when variant discovery is performed in a randomly
ascertained sample. Due to the high cost of sequencing, it may be
attractive to sequence a subset of a sample of individuals for
variant discovery and genotype the remaining samples, in
particular to sequence an excess of cases due to their potential
enrichment for causal variants. It was investigated how such
strategies impact type I error.
Results
Discovering Rare Variants at a Specific Site and across the
Genome
The probability of observing a variant at least once at a specific
site was calculated for variants with a frequency of 1%, 0.5%,
0.2%, and 0.1% in sample sizes of 100–1,000 individuals (Table 1).
The probability of observing a variant one or more times at a
unique site in a sample is equivalent to the average proportion of
variants discovered across genomes when linkage equilibrium is
assumed among variants with equal frequency and discovery is
carried out using the same number of individuals. It is observed
that for variants with 1% frequency, even if the genomes of only
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population from which the sample was ascertained will be
discovered. If the variant frequency is 0.1%, sequencing 100
genomes will only uncover 0.181 of all variants within the
population; if the sample size is increased to 1,000 genomes, the
proportion of variants discovered increases to 0.865 (Table 1).
The Probability of Observing Rare Variants with Equal
Frequencies within a Gene in a Randomly Ascertained
Sample
For a randomly ascertained sample, it was examined what
proportion of variants within a gene will be discovered if they are
assumed to be independent (i.e., in linkage equilibrium). For
example if a gene with 10 variants each with 1.0% frequency is
sequenced in a sample of 100 individuals, the probability is 0.860
that $8 variants and 0.237 that all 10 variants from the population
will be identified. If the sample size is increased to 1,000
individuals, the probability that all variants will be discovered is
close to 1.0. If the 10 variants within the gene have a frequency of
0.1%, then sequencing the gene in 100 individuals will uncover
$8 variants with probability 3.7610
25 and increasing the sample
size to 1,000 individuals will identify $8 variants with probability
0.857 and all variants with probability 0.234 (Table 2 and
Figure 1A).
For rare variants within genes a more realistic assumption is that
they reside on separate haplotypes and are not in linkage
equilibrium [16,17]. If rare variants do not lie on the same
haplotype with other rare variants, although the variants are in
complete LD (D’~1), the correlation is extremely low (r2&0).
Therefore there is little difference in the results when it is assumed
that the variants are on separate haplotypes (Table S1) or that they
are in linkage equilibrium (Table 2). There is also a possibility that
the rare variants are on the same haplotype and in this situation the
correlation between the two variants is high and r
2=1 when the two
rare variants have equal frequency. However, the probability that
two rare variants within a gene occur on the same haplotype is
extremely low and decreases with decreasing variant frequency.
Enrichment of Causal Rare Variants with Equal
Frequencies in Cases
If rare variants confer risk of being diseased, there is an
enrichment of rare causal variants in cases. The magnitude of
Table 1. The proportion of variants identified in samples
randomly ascertained from the population.
Frequency N=100 N=200 N=500 N=1,000
0.001 0.181(0.012) 0.330(0.015) 0.632(0.015) 0.865(0.011)
0.002 0.330(0.015) 0.551(0.016) 0.865(0.011) 0.982(0.004)
0.005 0.633(0.015) 0.865(0.011) 0.993(0.003) 1.000(2.1E-4)
0.01 0.866(0.011) 0.982(0.004) 1.000(2.1E-4) 1.000(1.4E-6)
The proportion of variants discovered assuming linkage equilibrium and their
standard deviations (shown in parentheses) in samples of N=100, 200, 500, and
1,000 individuals for variants with equal population frequencies of 0.001, 0.002,
0.005, and 0.01. Although the mean proportions of variants discovered are not
dependent on the number of variants in the genome, the standard deviations
will vary depending on the number of variants. The standard deviations shown
are for M=1,000 variants. All proportions of variants discovered displayed as 1.0
were rounded up and their actual values are between .0.999 and ,1.0.
doi:10.1371/journal.pgen.1000481.t001
Author Summary
One focus of human genetics is localizing genes that are
involved in the etiology of complex diseases. Although
emphasis has been placed on mapping common variants,
recent studies have demonstrated that rare variants also
play an important role in complex trait etiology and their
identification should have a greater impact on risk
assessment, disease prevention, and treatment due to
their large genetic effects. Genome-wide association
studies are used to identify common variants by genotyp-
ing tagSNPs that are proxies for common causal variants.
This study design is not adequately powered for associ-
ation studies of rare variants; instead, causal variants must
be identified and then analyzed. With the development of
sequencing technologies, it is feasible to sequence
candidate genes and, soon, entire genomes to obtain
data on rare variants for complex disease association
studies. We investigated several questions that are
germane to the discovery of rare variants within a sample;
for example, proportion of variants discovered within a
random sample and enrichment of causal variants within
samples of cases compared to a random sample. We also
demonstrate that when an excess of cases are sequenced
to discover variants and the remaining samples are
genotyped, this design strategy can lead to inflated false
positive rates.
Table 2. The probability of identifying rare variants with equal frequencies within a gene in samples of randomly ascertained
individuals.
M Frequency N=100 N=200 N=1,000
50% 80% 1.00% 50% 80% 100% 50% 80% 100%
10 0.001 0.0220 3.7E-5 3.8E-8 0.2060 0.0032 1.5E-5 0.9992 0.8571 0.2340
0.005 0.8836 0.2265 0.0103 0.9992 0.8584 0.2354 1.0000 1.0000 0.9996
0.01 0.9993 0.8600 0.2373 1.0000 0.9994 0.8343 1.0000 1.0000 1.0000
20 0.001 0.0012 3.1E-9 1.5E-16 0.0863 2.2E-5 2.3E-10 1.0000 0.8770 0.0547
0.005 0.9266 0.0903 0.0001 1.0000 0.8786 0.0554 1.0000 1.0000 0.9991
0.01 1.0000 0.8805 0.0563 1.0000 1.0000 0.6961 1.0000 1.0000 1.0000
The probability of discovering at least 50%, 80%, and 100% of variants within a gene with M=10 and 20 variants in linkage equilibrium with population frequencies of
0.001, 0.005, and 0.01 are displayed for samples of N=100, 200, and 1,000 individuals. All probabilities of identifying rare variants that are shown as 1.0 were rounded up
and their actual values are between .0.9999 and ,1.0.
doi:10.1371/journal.pgen.1000481.t002
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variant frequency, genotypic RR and disease model (Figure 1 and
Table 3). The relative increase is defined as the ratio of the
frequency of causal variants in cases compared to their frequency
in a randomly ascertained sample. If there is no difference between
variant frequencies in cases and the reference group of randomly
ascertained individuals, the relative increase is 1.0. If a gene has 10
causal variants each with a genotypic RR=2.0 and a frequency of
0.1% in the general population, under a dominant model there is a
1.96 relative increase in frequency of variants in cases compared to
a sample of randomly ascertained individuals; if the genotypic RR
is increased to 5.0, the relative increase almost doubles to 4.63
(Table 3). The relative increase in frequency of causal rare variants
with the same genotypic RR and population variant frequency is
greatest under the multiplicative model, followed by the additive
and dominant models with slightly smaller relative increases. For
the recessive model, the relative increase for identifying causal
variants in cases is very modest; for a gene with 10 casual variants
each with a frequency of 0.1% and a genotypic RR of 5.0, the
relative increase in frequency of causal variants is 1.04 (Table 3).
Figure 1. The probabilities of variant discovery for a gene with ten rare variants that have equal population frequency and reside
on separate haplotypes. Panels (A and B) display the probability of variant discovery in randomly ascertained samples when each of the variants
has a population frequency of 0.001 (Panel A) or 0.005 (Panel B). Panels (C and D) display the probability of discovering causal variants in samples of
cases when each of the ten rare variants has a genotypic RR=2.0 under a dominant model and population frequency of 0.001 (Panel C) or 0.005
(Panel D).
doi:10.1371/journal.pgen.1000481.g001
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underlying genetic model is multiplicative, additive or dominant,
sequencing causal genes in cases compared to sequencing a
randomly ascertained sample can substantially increase the
probability of causal variant discovery (Figure 1).
Rare Variants Discovery in Randomly Ascertained
Samples and Cases for Variants with a Mixture of
Frequencies
Although results assuming equal variant frequencies are easy to
interpret, they are not realistic. Therefore variant discovery was
also investigated using a more realistic distribution of rare variant
frequencies by generating the data using coalescent simulation.
Haplotype pools were generated under a neutral Wright–Fisher
model where the scaled mutation rate h~4Nem was set to 4. To
reduce the impact of randomness 100 haplotype pools were
generated with each pool containing 10,000 haplotypes. Since the
interest in this study is on rare variants, only those variants with
frequency $1% were investigated. The density of rare variants
which were generated using coalescent simulations is shown in
(Figure 2A). The distribution of rare variants is dominated by very
low frequencies; for example, 86% of rare variants have
frequencies ,0.5%. When sample size is small, the majority of
the rare variants are not observed in samples which are randomly
ascertained from the population (Figure 2B). For example, only
25% of the rare variants are observed in a sample of 100 randomly
ascertained individuals. When the sample size increases to 1,000
individuals, the proportion of discovered variants increases to
67%; even with this large sample size 33% of the variants are not
observed due to the large proportion of very rare variants
(Figure 2). Since the frequency distribution of variants is
independent of the scaled mutation rate h in coalescent
simulations, the proportion of variants discovered is approximately
the same for different h values (data not shown). To investigate
variants discovery in cases, half of the rare variants are randomly
chosen to be causal and it is assumed that all causal variants have
the same genotypic RR and the genetic model is additive (see
Methods). When a sample of cases is sequenced to discover rare
variants, the proportions of variants observed increase compared
to when a randomly ascertained sample is sequenced (Figure 2B).
For example, when the causal variants have a genotypic RR of 2.0,
31.1% of rare variants were observed in 100 cases and when the
genotypic RR is increased to 5, this proportion increases to 38.7%,
while for a randomly ascertained sample only 25.3% of the
variants were observed. Even for a large genotypic RR of 5 the
increase in the proportion of rare variant discovery is not dramatic
compared to when variant discovery is carried out in a randomly
ascertained sample (Figure 2). This is due to the fact that for
coalescent simulations very rare variants dominate and the
frequency of each rare variant in cases is still very low since this
frequency is roughly the population frequency of the rare variant
times its genotypic RR (see Table 3).
Type I Error for Rare Variants with Equal Frequencies
Due to the increased probability of detecting rare causal variants
in cases, it may be tempting to carry out discovery of variants in
cases and then genotype these variants in controls. We considered
the situation where variant identification is carried out in cases via
sequencing in a gene that is not involved in disease etiology and
these variants are genotyped in controls. The first scenario
considered is for a gene that has a fixed number of variants with
equal frequencies in the population. When the test of association is
carried outon the sampleof casesand controls,typeI errorrates are
inflated unless the case sample size is sufficiently large (Table 4). For
example, for a sample of 100 cases and 100 controls, the false
positive rate is 0.067 at a level of 0.05 for a gene with 10 variants
each with a frequency of 0.001; the false positive rate increases to
0.257 for a gene with 20 variants. We also examined the type I error
rate when a definite number of variants are observed in cases, since
in reality the true number of variants within a gene is unknown. If
variant discovery is carried out in 100 cases and 5 variants are
discovered each with a population frequency of 0.1% and these 5
variants are genotyped in 100 controls, the probability of rejecting
thenull hypothesis ofnoassociation is0.38(Table5).When variants
wereidentifiedinbothcasesandcontrols,thetypeIerrorrate iswell
controlled for varying sample sizes, number of variants and
frequencies (Tables 4 and 5). For the two situations described
where variant discovery is carried out in cases, type I error can be
even more inflated if two or three times the number of controls to
cases are genotyped (data not shown). Type I error inflation also
occurs when individuals with either high or low quantitative trait
values are sequenced to identify rare variants and individuals with
quantitative trait values from the other end of the spectrum are
genotyped. Type I error remains inflated, if variant discovery is
carried out in a subset which contains a greater proportion of cases
than controls or disproportionate numbers of individuals from one
end of the quantitative trait spectrum (data not shown).
Table 3. The relative increase in frequency of causal variants in samples of cases compared to samples of randomly ascertained
individuals.
RR Frequencya Multiplicative Dominant Additive Recessive
5 10 20 5 10 20 5 10 20 5 10 20
2 0.001 1.99 1.98 1.96 1.98 1.96 1.92 1.99 1.97 1.94 1.00 1.01 1.02
0.002 1.98 1.96 1.92 1.96 1.92 1.85 1.97 1.94 1.89 1.01 1.02 1.04
0.005 1.95 1.90 1.82 1.91 1.82 1.68 1.93 1.86 1.75 1.02 1.05 1.09
5 0.001 4.90 4.81 4.63 4.81 4.63 4.32 4.83 4.67 4.38 1.02 1.04 1.08
0.002 4.81 4.63 4.31 4.63 4.32 3.81 4.67 4.38 3.91 1.04 1.08 1.15
0.005 4.55 4.17 3.57 4.18 3.60 2.84 4.25 3.71 3.00 1.10 1.19 1.35
aFrequency of variants within the population.
The relative increase of causal variant frequency is shown for 5, 10, and 20 causal variants, each with equal population frequencies of 0.001, 0.002, and 0.005 and
genotypic RR of either 2 or 5 under a multiplicative, dominant, additive, and recessive model. The calculations were carried out under the assumption that the causal
variants reside on separate haplotypes.
doi:10.1371/journal.pgen.1000481.t003
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Frequencies
Coalescent simulation was used to generate rare variant data as
described in the Methods section. When simulation was used to
mimic the situation where variants discovery is performed in cases
and the controls are genotyped for those discovered variants,
inflated type I error at a level of 0.05 was observed for different h
values when the locus analyzed is neutral (Table 6). Since the
length of a simulated locus is proportional to the h value when the
size of a haplotype pool is fixed, the number of rare variants and
their total variant frequency increase with larger h values and
represent a longer locus or multiple loci (Table 6). Therefore the
type I error rate increases with increasing h values. For example,
the type I error rate is 0.124 for h=4 and a sample of 100 cases
Figure 2. Distribution of the frequencies of rare variants and the average proportion of rare variants discovered in randomly
ascertained and case samples. Data were generated using coalescent simulation under the neutral Wright–Fisher model with a scaled mutation
rate h=4. Panel (A) displays the distribution of rare variants with frequency #0.01 for 100 haplotype pools each with 10,000 haplotypes. Panel (B)
displays the mean proportion of variants discovered for randomly ascertained samples and for case samples of N=100, 200, 500, and 1,000
individuals. Results are based upon 10,000 replicates. Case samples were generated with 50% of rare variants randomly chosen to be causal each with
a genotypic RR of 2 or 5 under the additive model.
doi:10.1371/journal.pgen.1000481.g002
Table 4. False positive rates for association studies when variant identification is carried out in only cases or in both cases and
controls for gene(s) with a fixed number of neutral variants.
M=10 M=20 M=30
Discovery Sample N 0.001 0.002 0.005 0.001 0.002 0.005 0.001 0.002 0.005
Cases Only 100 0.067 0.140 0.115 0.260 0.346 0.235 0.447 0.562 0.374
200 0.144 0.132 0.055 0.350 0.273 0.083 0.553 0.430 0.113
500 0.107 0.055 0.048 0.219 0.079 0.049 0.334 0.104 0.049
1,000 0.057 0.047 0.050 0.078 0.048 0.050 0.102 0.048 0.050
Cases and Controls 100 0.039 0.043 0.051 0.042 0.050 0.050 0.046 0.050 0.050
200 0.045 0.049 0.049 0.049 0.048 0.050 0.048 0.050 0.050
500 0.050 0.049 0.050 0.049 0.050 0.050 0.049 0.050 0.050
1,000 0.051 0.050 0.050 0.050 0.050 0.050 0.050 0.050 0.050
Results are shown for gene(s) with M=10, 20, and 30 neutral variants with equal population frequencies of 0.001, 0.002, and 0.005, for N=100, 200, 500, and 1,000 cases,
and an equal number of controls. The assumption is made that the variants reside on separate haplotypes. The upper panel shows the false positive rates when only
cases are used for variant discovery and the discovered variants are genotyped in controls. The lower panel shows the false positive rates when both case and controls
are sequenced to discover rare variants. Analyses were carried out using the Cochran–Armitage test for trend (see Methods). The false positive rates were evaluated for
an a=0.05 and based upon 100,000 replicates.
doi:10.1371/journal.pgen.1000481.t004
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sample size of cases and controls (Table 6). For all h values, the
type I error rate decreases with increasing sample size and when
the sample size is 1,000 cases and 1,000 controls, the type I error
rate is very close to the a value of 0.05. For all sample sizes and h
values, when both cases and controls were used to discover rare
variants, no inflated type I error rates were observed (Table 6).
Since the data were generated using the neutral Wright–Fisher
model without recombination, it was investigated whether it is
valid to use larger h values for the situation where multiple loci are
combined to be analyzed. Two loci for each individual were
obtained from two independent haplotype pools each generated
using a scaled mutation rate h=6. These results are very similar to
those obtained when individual genotypes were sampled from a
single haplotype pool generated using h=12 (data not shown).
This is an indication that recombination between loci should have
little impact on the results.
Discussion
The 1,000 Genomes Project will bring to light a wealth of
information on human variation and should be able to capture a
vast majority of variants with a frequency of .1%. A detailed
catalog of variants should aid association studies of complex traits
to study variants which range from common to rare. It is
hypothesized that rare causal variants for complex diseases are
usually found in the frequency range between 0.1% and 1%,
although the boundaries are not absolutely defined [13]. The
1,000 Genomes Project will also identify very rare variants (e.g.,
frequency ,0.5%), however, the study’s ability to discover a
substantial proportion of very rare variants will be dependent on
whether or not very rare variants are shared across multiple
populations, because individual ethnic groups which are included
in the project will have a limited sample size, ,100 individuals.
Many rare variants have occurred in recent human history and
therefore they may not be shared among different populations.
Thus the 1,000 Genomes Project currently does not have an
adequate sample size to provide a comprehensive catalog of very
rare variants which could be selected for genotyping in association
studies of complex traits.
Although assuming equal variant frequencies is not realistic, it is
easier to interpret these results than when a mixture of variant
frequencies is used. To also investigate a more realistic situation
where variants have a mixture of frequencies, coalescent
simulation was used by generating haplotype pools under a
neutral Wright–Fisher model with the assumption of no
recombination. The simulation of haplotypes which reflect
evolutionary history of human populations has been well
researched and a neutral Wright–Fisher model is commonly used.
For genes the impact of recombination is negligible due to gene
length and genome-wide surveys [18] have shown that recombi-
Table 5. False positive rates for association studies when a
definite number of neutral variants are identified only in cases
or when variant discovery is carried out in cases and controls.
M=5 M=10
Discovery
Sample N 0.001 0.002 0.005 0.001 0.002 0.005
Cases Only 100 0.389 0.211 0.087 0.864 0.584 0.186
200 0.217 0.111 0.045 0.579 0.245 0.060
500 0.080 0.046 0.047 0.175 0.058 0.048
1,000 0.047 0.047 0.051 0.060 0.047 0.050
Cases and
Controls
100 0.040 0.038 0.047 0.050 0.052 0.051
200 0.040 0.045 0.047 0.053 0.049 0.050
500 0.042 0.051 0.048 0.05 0.048 0.049
1,000 0.051 0.052 0.050 0.052 0.050 0.050
The false positive rates are displayed for when M=5 or 10 neutral variants with
equal population frequencies of 0.001, 0.002, and 0.005 were discovered in
cases (upper panel) or in both cases and controls (lower panel) for N=100, 200,
500, and 1,000 cases with equal number of controls. It is assumed that each rare
variant resides on a separate haplotype. Analyses were carried out using the
Cochran–Armitage test for trend (see Methods). The false positive rates were
evaluated for an a=0.05 and based upon 100,000 replicates.
doi:10.1371/journal.pgen.1000481.t005
Table 6. False positive rates for rare variant association studies when variants are identified only in cases or in both cases and
controls for variants with a mixture of frequencies.
Number of Cases
a
Discovery Sample h Number of variants
b Frequency
c 100 200 500 1,000
Cases Only 4 21.0 0.0403 0.124 0.094 0.066 0.056
6 31.5 0.0628 0.178 0.122 0.076 0.062
8 41.9 0.0835 0.228 0.146 0.085 0.066
12 61.7 0.1160 0.325 0.205 0.106 0.075
Cases and Controls 4 21.0 0.0403 0.048 0.050 0.050 0.050
6 31.5 0.0628 0.050 0.047 0.049 0.049
8 41.9 0.0835 0.048 0.048 0.051 0.051
12 61.7 0.1160 0.049 0.049 0.049 0.051
aThe number of controls is equal to the number of cases.
bNumber of rare variants with frequency #1% observed per haplotype pool averaged over 100 haplotype pools.
cTotal frequency of rare variants with frequency #1% observed per haplotype pool averaged over 100 haplotype pools.
Coalescent simulations with scaled mutation rates h ranging between 4 and 12 were used to generate genotype data for rare variants with frequencies between 0.0001
and 0.01 for samples of N=100, 200, 500, and 1,000 cases. The false positive rates are displayed when variant discovery is carried out in only cases via sequencing and
the discovered variants are genotyped in controls (upper panel) and when both cases and controls are sequenced to discover rare variants (lower panel). Analyses were
carried out using the Cochran–Armitage test for trend (see Methods). The false positive rates were evaluated for an a=0.05 and based upon 100,000 replicates.
doi:10.1371/journal.pgen.1000481.t006
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preferentially transpire outside gene boundaries. However, in
reality genetic regions may display different distributions of variant
frequencies than those obtained using coalescent simulation and
therefore rare variant discovery may exhibit different results.
If it is believed that very rare variants contribute to disease
etiology, sequencing of the study sample will be necessary to
identify them. Although causal variants will be enriched in case
samples, most genomic regions which are sequenced will not be
involved in disease etiology. If cases are sequenced and the
identified rare variants are genotyped in controls, this can lead to
an increase in type I error, with the estimate of the OR being
.1.0. The increase in type I error can also occur if the controls are
sequenced and the cases are genotyped since the genes are not
causative; in this situation the estimate for the OR will be ,1.0.
For situations where different proportions of cases and controls are
sequenced and the remaining samples are genotyped, type I error
may also be inflated. In a similar fashion, if to identify rare variants
the exons of a gene are sequenced in cases and only those exons
where rare variants were detected are sequenced in the controls,
type I error can also be inflated. The differences in the variant
frequencies between cases and controls are intrinsic to this study
approach and cannot be controlled for by permutation. This
inflation of type I error will not occur if the subjects that are used
for variant discovery are not included in the association study.
Whether or not an inflation of type I error occurs is dependent on
the size of the initial sample which is sequenced, variant
frequencies and the number of variants within the gene/genomic
region. If the analysis is done on a specific gene/region, the level of
type I error inflation is not monotonic with sample size or variant
frequency as shown in Table 4. The type I error is a function of
both the sample size and the difference in variant frequency
between cases and controls. For small sample sizes, although the
frequency difference between cases and controls is great the power
to detect the difference is low due to sample size. On the other
hand, for large sample sizes the variant frequency difference
between cases and controls is small and the power to detect these
small differences is also low, even though the sample size is large.
Therefore the greatest inflation of type I error occurs for a
moderate sample size and the exact sample size depends on the
population frequency of rare variants. Although a monotone
decrease in type I error was observed with increasing sample sizes
for the examples displayed in Table 5 and Table 6, monotonicity
was violated when smaller sample sizes were analyzed (data not
shown) demonstrating that monotonicity is not always the rule.
Since neither the frequencies of variants in a population nor the
number of variants within the gene/genomic region are known a
priori, it is not possible to elucidate whether or not type I error has
been inflated if variant discovery is carried out in a preponderance
of cases.
Collapsing of genotypes was used for the association tests. It is
also possible to analyze each variant separately, however for this
approach to have sufficient power extremely large sample sizes will
be necessary [12], with sample sizes increasing with decreasing
variant frequencies and genotypic RRs. Power is particularly low
when variants are either recent or de novo. Collapsing has been
shown to be a powerful approach to analyze rare and very-rare
variants [19] and therefore we used it in our analyses.
Since mutation rates are unlikely to vary in different
populations, it might be tempting to use the data from the 1,000
Genomes Project as a reference control population for various
studies of complex traits. However the aggregate frequencies of
rare variants in a genomic region may vary greatly from one ethnic
group to another [13,20] due to different evolutionary histories
including genetic drift and bottlenecks. There are a number of
examples where rare causal variants (e.g., variants in the CFTR,
BRCA1, and BRCA2 genes) have higher frequencies within the
Ashkenazi Jewish population compared to other European Jewish
and non-Jewish populations [21,22]. In addition to rare causal
variants having varying frequencies within ethnic groups, rare
neutral variants may also have diverse frequencies which can lead
to an increase of type I error if population substructure is not
adequately controlled [23]. In the study of rare variants, it is
currently unknown if a consensus panel of controls can be used; for
example, a European panel for complex trait association studies of
Europeans and individuals of European descent, or if more
stringent matching criteria are necessary. Additionally it has not
been investigated if implementing current statistical methods; for
example, principal components analysis [24] using common
variants will adequately control population substructure when
analyzing rare variant data.
Studies of rare variants for complex traits are beginning to
emerge and in the near future a large number of studies will be
carried out for a variety of common diseases. Although there are
many challenges in understanding the involvement of rare variants
in complex disease etiology, one benefit from the study of rare
variants compared to common variants is that rare variants have
higher genotypic RRs, not only making it easier to implicate them
in complex disease etiology but also the identification of rare
variants should have a greater impact on risk assessment, disease
prevention and treatment [13].
Methods
Probability of Observing Rare Variants That Are in
Linkage Equilibrium in a Randomly Ascertained Sample
Let the number of variants equal M and each variant site has
two alleles A and a with a minor allele frequency of p.I ti s
assumed that N individuals are sampled from a population where
Hardy-Weinberg Equilibrium (HWE) holds. If all variants in a
sample are successfully identified via sequencing (i.e., no false
negatives), the probability of observing a specific variant one or
more times within a randomly ascertained sample is
q~
P2N
i~1
2N
i
  
pi 1{p ðÞ
2N{i~1{ 1{p ðÞ
2N. Under the assump-
tion of linkage equilibrium (LE) between variants, the probability
of discovering m or more different variants in the randomly
ascertained sample is fm~
PM
j~m
M
j
  
qj 1{q ðÞ
M{j,m~0,:::,M.
Probability of Observing Rare Variants That Are on
Separate Haplotypes in a Randomly Ascertained Sample
Usually rare variants are relatively young and reside on separate
haplotypes within a candidate gene or small genomic region and
additionally within small genomic regions there is little or no
recombination [16,17]. We assumed that within a gene rare
variants are on different haplotypes and there is no recombination.
In this situation, rare variants are not independent. Although they
are in complete LD (D’~1), the correlation between the variants is
extremely low; that is, r2~ D2
p1 1{p1 ðÞ p2 1{p2 ðÞ ~
{p1p2 ðÞ
2
p1 1{p1 ðÞ p2 1{p2 ðÞ
&p1p2&0 where p1, p2 are the frequencies of two rare variants.
In this situation, under the assumption of HWE, the number of
variants with equal frequency observed in a sample follows a
multinomial distribution with parameter 2N and H~
p,p,...,p,Q ðÞ where H is a vector of size Mz1 and p and
Q~1{Mp are the frequencies of each rare variant bearing
haplotype and non-rare variants bearing haplotype, respectively. A
discrete Markov Chain (MC) was constructed to facilitate the
calculation of the probability of observing m or more variants in a
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individuals can be treated as a realization of MC where the process
is that 2N chromosomes are sampled one at a time assuming
HWE. Let S~ 0,1,...,M fg denote the state space and let Sn~i
represent the event that i variants are observed at time n; that is,
when n chromosomes are sampled. When sampling the (n+1)
th
chromosome, the transition from state Sn~i to Snz1~j occurs
when j~iz1 or j~i, corresponding to when one or zero
additional variants are observed. The transition matrix is
P~
0
1
2
3
:::
M
Q 1{Q 00 ::: 0
0 Qzp 1{Q{p 0 ::: 0
00 Qz2p 1{Q{2p ::: 0
00 0 Qz3p ::: 0
::: ::: ::: ::: ::: 0
00 0 0 0 1
2
6 6 6 6 6 6 6 6 4
3
7 7 7 7 7 7 7 7 5
where the column outside of the matrix are the states. Let the row
vector p of length M+1 denote the probability distribution of
observing k of M variants where k=0,1,…,M. Then the initial
probability vector p0~ 1,0,...,0 ½  , denoting that no variants are
observed when no chromosomes are sampled. The probability
distribution of the number of variants observed in a sample of N
individuals is p~p0P2N and the probability of observing
m~0,1,...,M or more variants is fm~
PM
i~m p i ½  , m~0,1,
...,M.
Probability of Observing Variants That Are on Separate
Haplotypes in a Sample of Cases
Suppose each of M causal variants resides on a separate
haplotype and independently increases disease susceptibility (i.e.,
allelic heterogeneity model). Denote the haplotypes as
h0,h1,...,hM with frequency q0,q1,...,qM where h0 represents
the non-rare variants bearing haplotype and h1,...,hM are high
risk haplotypes carrying rare variants. Let the penetrance of
genotype hihj be represented by fij; that is, fij~pDh i,hj
      
. Define
the marginal haplotype penetrance of hi, denoted by wi, as the
probability of being diseased if an individual carries the haplotype
hi; that is, wi~pDh i j ðÞ ~
PM
j~0 pDh i,hj
      
ph j
  
~
PM
j~0 fijqj un-
der the assumption of HWE. The frequency of haplotype hi in
cases is qD
i ~wiqi=K~riqi where K~
PM
j~0 wjqj is the disease
prevalence and ri~wi=K is the ratio of relative increase of variant
frequency in cases compared to a randomly ascertained sample.
When it was assumed that all variants have the same genetic effect,
denote the penetrances of genotype h0h0, hih0 and hihj as f0, f1
and f2 respectively and define the genotypic RR c1~f1=f0 and
c2~f2=f0. For multiplicative, additive, dominant, and recessive
models, the RRs satisfy c2~c2
1, c2~2c1{1, c2~c1 and c1~1,
respectively.
Effect on Type I Error of Association Studies When Variant
Discovery Is Only Performed in Cases
Suppose rare variants are discovered in cases via sequencing
and then those variants are genotyped in controls. When the
sequenced gene is not involved in the etiology of the disease under
study, the variants observed in cases are independent of the cases
status. Conditional on the fact that a variant with frequency p has
been observed at least once in cases, the mean number of times the
variant is observed in cases at the marker is nA~
P 2N
k~1kP k ðÞ
 
1{P 0 ðÞ ðÞ ~2Np= 1{P 0 ðÞ ðÞ where k follows binomial (2N, p)
distribution for a sample of N cases and the mean number of times
that this variant is observed in the same number of controls is
nA~2Np. Since nAwnA, this may create false positive associa-
tions. Since analyzing variants individually is underpowered [12],
it is advisable to collapse multiple variants across the M markers at
the locus to increase power to detect associations [19]. In this study
the locus with multiple rare variants is collapsed in such a way that
the locus of one individual is coded using the number of rare
variants this individual carries; in this way multiple variants are
collapsed into a single number. The association test is used to test
whether one or more rare variants are associated with the disease.
Under the allelic heterogeneity model that multiple rare variants
cause the disease independently, it is expected that a locus with
more variants has a higher probability of being diseased and the
Cochran–Armitage test for trend is natural to use where the
ordered categories are the number of variants present at a locus.
The false positive rates were evaluated using simulated data
assuming rare variants reside on separate haplotypes. For
simplicity it was assumed all haplotypes have the same frequency
q and q~0:001, 0.002 and 0.005 were used as examples. For the
scenario where the number of variants at a locus within the
population is fixed, the genotype for each individual was
constructed by randomly sampling two haplotypes and then was
randomly assigned to either the case or control sample. This
process was repeated until the desired sample size was obtained for
both cases and controls. Only those variants which are observed in
cases are analyzed in the case-control dataset. For the situation
where both cases and controls are sequenced, the same procedure
was performed except that variants observed in either cases or
controls were included in the analysis. For the scenario where a
definite number of variants are observed in cases, the genotype for
each individual was constructed by randomly sampling two
haplotypes of length L~100 and then randomly assigned to
either the case or control sample. This process was repeated until
the desired sample size was obtained. Among the variants which
were observed in cases, a total of either M~5 or 10 variants were
randomly selected and then the M variants were analyzed in the
case-control dataset. In order to perform the simulation for the
situation where variant discovery is performed in both cases and
controls, M variants were randomly selected in the sample (cases
and controls) and then the M variants were analyzed in the case-
control dataset. For each study the analyses were repeated
R~100,000 times and the type I error rate was estimated for
the a level of 0.05 by calculating the proportion of replicates with p
values ƒa.
Rare Variants Discovery and Evaluation of Type I Error
Rates for Variants with a Mixture of Frequencies Using
Coalescent Simulation
Although the results are easier to interpret when all variants
have equal frequency, rare variants usually have a mixture of
frequencies at a locus within a population. To investigate the
variant discovery and type I error rates in a more realistic scenario,
coalescent simulator ms [25] was used to generate haplotype pools
to represent a population. The scaled mutation rate of a locus,
h~4Nem, was set to values between 4 and 12 to represent different
locus lengths, and 10,000 haplotypes were simulated for each
haplotype pool assuming no recombination within the locus. To
reduce randomness of coalescent simulation, 100 replicates were
generated for each h value. Since the interest is on rare variants,
only variants with frequencies between 10610
24 and 10610
22
were analyzed. To generate a sample, a haplotype pool was
randomly selected and all individuals’ genotypes are formed by
randomly pairing two haplotypes from this pool. For randomly
ascertained samples, N individuals were selected from the
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or control status according to the penetrance of the genotype. It is
assumed that not all variants are causal and 50% of variants are
assigned to be causal with the same genotypic relative RR. The
penetrace of the genotype follows an additive model and is
calculated as m*c1*e0, where m is the number of rare causal
variants the individual carries at the locus, c1 is the RR of the
genotype carrying one causal variant versus the genotype carrying
no causal variants and c1=2 and 5 were used. This process is
repeated until the desired sample size was obtained. For either the
randomly ascertained sample or the case sample, variant discovery
is performed by examining each position of the locus and counting
the number of variants observed at the locus in the sample.
For evaluation of type I error, an individual was generated by
pairing two random haplotypes from a haplotype pool and was
randomly assigned to case or control status. The process was
repeated until the desired sample size was obtained. The type I
error rates were estimated based on 100,000 replicates for an a
level of 0.05 in the same manner as described in the previous
Methods section for the scenario where the number of variants at a
locus within the population is fixed.
Supporting Information
Table S1 The probability of identifying rare variants with equal
frequencies in samples of randomly ascertained individuals when
the rare variants residue on separate haplotypes.
Found at: doi:10.1371/journal.pgen.1000481.s001 (0.05 MB
DOC)
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